David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 2,700 shares at $99.75 ($269K) on 2016-12-02, disclosed to the SEC on 2016-12-06.
Open-market sale of $269k ICPT by CMO and EVP - Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.75 | 1,350 | $135K | 50.0% |
| 2 | $99.75 | 1,350 | $135K | 50.0% |
| Total | $99.75 avg | 2,700 | $269K | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |